Evidence map›Paper›PMID 42698004›Full record

ArticleNature metabolism2026

Author Correction: Impaired cAMP-PKA-CREB1 signalling drives mitochondrial dysfunction in skeletal muscle during cancer cachexia.

Elia Angelino, Lorenza Bodo, Roberta Sartori, Valeria Malacarne, Beatrice D'Anna, Nicolò Formaggio, Suvham Barua, Tommaso Raiteri, Andrea Lauria, Simone Reano and 20 more

Abstract readPublished Erratum
In one paragraph

Article in Nature metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Elia Angelino *Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy. elia.angelino@unito.it.
Lorenza Bodo *Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy.
Roberta SartoriDepartment of Biomedical Sciences, University of Padova, Padova, Italy.
Valeria MalacarneDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy.
Beatrice D'AnnaDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy.
Nicolò FormaggioInstitute of Oncology Research, Università della Svizzera italiana, Lugano, Switzerland.
Suvham BaruaDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy.
Tommaso RaiteriDepartment of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Andrea LauriaDepartment of Life Sciences and Systems Biology, University of Turin, Turin, Italy.
Simone ReanoCenter on Autoimmune and Allergic Diseases, University of Piemonte Orientale, Novara, Italy.
Alessandra MurabitoDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy.
Monica NicolauDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy.
Fabiana FerreroDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy.
Camilla PezziniDepartment of Biomedical Sciences, University of Padova, Padova, Italy.
Giulia RossinoDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy.
Francesco FaveroDepartment of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Michele ValmasoniDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
Nicoletta FilighedduDepartment of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Alessio MengaCenter on Autoimmune and Allergic Diseases, University of Piemonte Orientale, Novara, Italy.
Davide CoràDepartment of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Emilio HirschDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy.
Salvatore OlivieroDepartment of Life Sciences and Systems Biology, University of Turin, Turin, Italy.
Vittorio SartorelliLaboratory of Muscle Stem Cells and Gene Regulation, NIAMS, NIH, Bethesda, MD, USA.
Valentina ProserpioDepartment of Life Sciences and Systems Biology, University of Turin, Turin, Italy.
Alessandra GhigoDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy.
Marco SandriDepartment of Biomedical Sciences, University of Padova, Padova, Italy.
Paolo E PorporatoDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy.
Daniela TalaricoIRCCS Ospedale San Raffaele, Comprehensive Cancer Center, Milan, Italy.
Giuseppina CarettiDepartment of Biosciences, University of Milano, Milan, Italy.
Andrea GrazianiDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Turin, Turin, Italy. andrea.graziani@unito.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42698004
PMCPMC13597296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.